Display options
Share it on

Clin Kidney J. 2021 Nov 11;14:i1-i4. doi: 10.1093/ckj/sfab224. eCollection 2021 Dec.

Deciphering the core elements around haemodialysis therapy.

Clinical kidney journal

Sudhir K Bowry, Alberto Arduan Ortiz, Frank W Maddux

Affiliations

  1. Dialysis-at-Crossroads (D@X) Advisory, Bad Nauheim, Germany.
  2. Nephrology and Hypertension. IIS-Fundación Jiménez Díaz-Universidad Autónoma Madrid, Madrid, Spain.
  3. Global Medical Office, Waltham, MA, USA.

PMID: 34987781 PMCID: PMC8711757 DOI: 10.1093/ckj/sfab224

Abstract

The projected future demand for renal replacement therapies for patients with end-stage renal failure requires preparedness at different levels. The deliberations focus predominantly on the disproportionately high financial burden of care for patients on routine dialysis therapy compared with other chronic conditions. However, even today there are concerns regarding the shortage of healthcare workers in the field of nephrology. A substantial increase in trained healthcare professionals is needed for the future delivery and care of patients requiring haemodialysis (HD) that 89% of patients on dialysis receive; a sustainable health workforce is the cornerstone of any healthcare system. The multimorbid nature of chronic kidney disease as well as the complexity-especially the technical aspects-of HD are deterrents for pursuing nephrology as a career. An educational platform that critically examines the essential issues and components of HD therapy was thus considered appropriate to create or renew interest in nephrology. By providing broader and newer perspectives of some of the core principles around which HD evolves, with this set of articles we seek to facilitate a better appreciation of HD. We believe that such a reappraisal of either poorly understood or ill-defined principles, including usage of terminology that is imprecise, will help facilitate a better understanding of the functioning principles of HD.

© The Author(s) 2021. Published by Oxford University Press on behalf of ERA.

Keywords: biocompatibility; evidence-based medicine; hemodialysis; membranes; sustainability

References

  1. Lancet. 2015 May 16;385(9981):1975-82 - PubMed
  2. Kidney Int Suppl (2011). 2018 Feb;8(2):52-63 - PubMed
  3. Drugs. 2019 Mar;79(4):365-379 - PubMed
  4. Semin Dial. 2018 Mar;31(2):183-192 - PubMed
  5. Lancet. 2021 Aug 28;398(10302):786-802 - PubMed
  6. Clin Kidney J. 2020 Dec 24;14(1):107-123 - PubMed
  7. Kidney Int. 2012 Feb;81(3):307-13 - PubMed
  8. BMJ Glob Health. 2021 Jan;6(1): - PubMed
  9. J Nephrol. 2008 Mar-Apr;21(2):146-60 - PubMed
  10. Kidney Int. 2015 Sep;88(3):460-5 - PubMed
  11. Nat Rev Nephrol. 2017 Jul;13(7):393-409 - PubMed
  12. Cardiorenal Med. 2019;9(5):334-336 - PubMed
  13. Nat Rev Nephrol. 2020 Oct;16(10):573-585 - PubMed
  14. Clin Kidney J. 2016 Feb;9(1):11-22 - PubMed
  15. Lancet. 2020 Oct 17;396(10258):1204-1222 - PubMed
  16. Semin Dial. 2016 Mar-Apr;29(2):93-102 - PubMed
  17. Artif Organs. 1981;4 Suppl:1-2 - PubMed
  18. Semin Dial. 2019 Sep;32(5):424-437 - PubMed
  19. Clin Sci (Lond). 2017 Jan 1;131(1):3-12 - PubMed
  20. Nephrol Dial Transplant. 2018 Jan 1;33(1):4-12 - PubMed
  21. Clin Nephrol. 2020 Supplement Jan;93(1):21-30 - PubMed
  22. Kidney Int Rep. 2019 Dec 06;5(2):135-148 - PubMed
  23. Int J Environ Res Public Health. 2019 Mar 04;16(5): - PubMed
  24. Nephrol Dial Transplant. 2016 Aug;31(8):1251-61 - PubMed
  25. Lancet. 2015 May 16;385(9981):1926-8 - PubMed
  26. Ann Palliat Med. 2020 Nov;9(6):3877-3884 - PubMed
  27. Prim Care. 2020 Dec;47(4):585-595 - PubMed
  28. Lancet. 2013 Jul 20;382(9888):260-72 - PubMed

Publication Types